FIELD: pharmaceutics.
SUBSTANCE: invention relates to the pharmaceutical industry, and in particular to an agent for the treatment of arthrological diseases. An agent for the treatment of arthrological diseases, including the Na-salt of chondroitin sulfate in the form of a lyophilized powder, as the agent does not contain preservatives, with the following ratio of components: lyophilized powder of chondroitin sulfate 95-120 mg, including chondroitin sulfate 9.0-11.5 wt. %.
EFFECT: product is safer due to the absence of preservatives.
2 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR TREATMENT OF ARTHROLOGIC DISEASES | 2015 |
|
RU2612014C1 |
| PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739747C1 |
| PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739746C1 |
| PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739184C1 |
| PHARMACEUTICAL AGENT FOR TREATING ARTHROLOGICAL DISEASES | 2023 |
|
RU2813891C1 |
| METHOD OF PREPARING THE PREPARATION CHONDROITIN SULFATE INJECTION FORM | 1994 |
|
RU2080857C1 |
| METHOD OF PREPARING INJECTION FORM OF CHONDROITIN SULPHATE | 2015 |
|
RU2580589C1 |
| PRODUCTION METHOD OF PREPARATION INJECTABLE FORM BASED ON SULFATE CHONDROITIN | 2015 |
|
RU2612019C1 |
| AGENT FOR ARTHROLOGICAL DISEASES TREATMENT | 1992 |
|
RU2021812C1 |
| CHONDROITIN SULFATE SOLUTION FOR INTRAMUSCULAR ADMINISTRATION AND METHOD FOR ITS PREPARATION | 2015 |
|
RU2623050C2 |
